These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2245807

  • 21. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
    Hainsworth JD, Grosh WW, Burnett LS, Jones HW, Wolff SN, Greco FA.
    Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
    Young RC, Brady MF, Nieberg RK, Long HJ, Mayer AR, Lentz SS, Hurteau J, Alberts DS.
    J Clin Oncol; 2003 Dec 01; 21(23):4350-5. PubMed ID: 14645424
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
    Chiara S, Conte PF, Bruzzone M, Falcone A, Sertoli MR, Carnino F, Mossetti C, Iura R, Durando C, Guercio E.
    Chemioterapia; 1987 Oct 01; 6(5):380-3. PubMed ID: 3427698
    [Abstract] [Full Text] [Related]

  • 28. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS, Lele SB, Marchetti DL, Baker TR, Emrich LJ, Hartman AB.
    J Clin Oncol; 1988 Nov 01; 6(11):1679-84. PubMed ID: 3183700
    [Abstract] [Full Text] [Related]

  • 29. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study.
    Randall ME, Barrett RJ, Spirtos NM, Chalas E, Homesley HD, Lentz SL, Hanna M.
    Int J Radiat Oncol Biol Phys; 1996 Jan 01; 34(1):139-47. PubMed ID: 12118543
    [Abstract] [Full Text] [Related]

  • 30. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.
    Forum (Genova); 2000 Jan 01; 10(4):323-32. PubMed ID: 11535983
    [Abstract] [Full Text] [Related]

  • 31. Clinical analysis and evaluation of the results of adjuvant treatment (radiotherapy and chemotherapy) in ovarian carcinoma.
    Pietrzak K, Sablińska B, Zieliński J.
    Eur J Gynaecol Oncol; 1993 Jan 01; 14 Suppl():133-9. PubMed ID: 7515347
    [Abstract] [Full Text] [Related]

  • 32. Current therapies in ovarian cancer.
    Fields AL, Runowicz CD.
    Cancer Invest; 2003 Jan 01; 21(1):148-56. PubMed ID: 12643016
    [No Abstract] [Full Text] [Related]

  • 33. Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.
    Chambers JT, Chambers SK, Kohorn EI, Carcangiu ML, Schwartz PE.
    Gynecol Oncol; 1996 Mar 01; 60(3):438-42. PubMed ID: 8774654
    [Abstract] [Full Text] [Related]

  • 34. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.
    J Clin Oncol; 1991 Sep 01; 9(9):1668-74. PubMed ID: 1831495
    [Abstract] [Full Text] [Related]

  • 35. The sequential multiple modality treatment of ovarian cancer.
    Dembo AJ.
    Radiother Oncol; 1985 Apr 01; 3(3):187-92. PubMed ID: 3923573
    [No Abstract] [Full Text] [Related]

  • 36. Five-year survival for cisplatin-based chemotherapy versus single-agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery.
    River MS, Fanning J, Sprance HE.
    J Surg Oncol; 1991 Sep 01; 48(1):39-44. PubMed ID: 1890837
    [Abstract] [Full Text] [Related]

  • 37. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
    Shapiro F, Schneider J, Markman M, Reichman BS, Venkatraman E, Barakat R, Almadrones L, Spriggs D.
    Gynecol Oncol; 1997 Oct 01; 67(1):39-45. PubMed ID: 9345354
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cyclophosphamide and cisplatinum combination chemotherapy for the treatment of epithelial ovarian carcinoma.
    Hahn K, Magrina JF, Masterson BJ.
    Int J Gynaecol Obstet; 1985 Dec 01; 23(6):509-13. PubMed ID: 2868947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.